Font Size: a A A
Keyword [non-muscle invasive bladder cancer]
Result: 121 - 138 | Page: 7 of 7
121. Experimental Study On Urine Endogenous Cannabinoid As A Diagnostic Biomarker For Non-Muscle-Invasive Bladder Cancer
122. A Meta-analysis Of The Safety And Efficacy Of Endoscopic Submucosal Dissection In The Treatment Of Non-muscle-invasive Bladder Tumors
123. Correlation Of Preoperative Plasma Fibrinogen And Systemic Immune-inflammation Index With Prognosis Of Non-muscle Invasive Bladder Cancer
124. Efficacy Analysis Of Thulium Laser En-bloc Resection Of Bladder Tumor Versus Plasm Akinetic Transurethral Resection Of Bladder Tumor For Non-muscle Invasive Bladder Cancer
125. Preoperative Sarcopenia And Systemic Immune-inflammation Index Can Predict Response To Intravesical Bacillus Calmette-Guerininstillation In Patients With Non-muscle Invasive Bladder Cancer
126. Research On The Correlation Between Preoperative Urine PH And The Recurrence Of Non-Muscle-Invasive Bladder Cancer Patients,and The Development And Validation Of A Recurrence Risk Model
127. Association Between Metabolic Syndrome And Its Components And Non-muscle Invasive Bladder Cancer
128. Postoperative Adjuvant Iliac Artery Perfusion Chemotherapy For The Treatment Of High-risk Non-muscular Invasion Efficacy Of Bladder Cancer:A Meta-analysis
129. Construction Of A Model To Predict The Risk Of Recurrence Of Non-muscle Invasive Bladder Cancer Using Pathological Images Combined With Deep Learning
130. Predictive Role Of RPN1 In The Recurren Of Non-muscle Invasive Bladder Cancer After Surgery
131. The Value Of Systemic Inflammatory Markers In The Prognosis Of Patients With Non-Muscle Invasive Bladder Cancer
132. Study On The Diagnostic Value Of Ⅵ-RADS Combined With Quantitative Parameters For Invasiveness Of Bladder Urothelial Carcinoma
133. Effect Of Intravesical Instillation Of Epirubicin,gemcitabine And Pirarubicin On Recurrence And Progression Of NMIBC
134. Therapeutic Effect Of Chemohyperthermia On Non-muscle Invasive Bladder Cancer And Predictive Roles Of Its Prognosis By The Peripheral Blood Indicators
135. To Develop A New Recurrence Risk Prediction Model For Non-muscular Invasive Bladder Cancer
136. A Real-world Study Comparing Gemcitabine Followed By BCG Intravesical Instillation With BCG Alone In The Prevention Of Postoperative Recurrence Of Intermediate And High-risk Non-muscle Invasive Bladder Cancer
137. Albumin-to-fibrinogen Ratio Combining With Tumor Features Established A Model For Predicting NMIBC Pathological Progression
138. Correlation Analysis Of The Effect Of Areca Nut Chewing On Recurrence And Progression Of Non-muscular Invasive Bladder Cancer
  <<First  <Prev  Next>  Last>>  Jump to